Quantifying dementia prevention potential in the FINGER randomized controlled trial using the LIBRA prevention index
Kay Deckers1, Sebastian Köhler1, Tiia Ngandu2,3
1Alzheimer Centrum Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
Summary
The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) found that a multi-domain lifestyle intervention improved brain health regardless of baseline risk. The LIfestyle for BRAin Health (LIBRA) score effectively monitored intervention success.
Area of Science:
- Gerontology
- Neuroscience
- Public Health
Background:
- Dementia prevention trials may yield varied benefits based on participants' baseline risk.
- Modifiable dementia risk scores can serve as valuable surrogate or intermediate outcomes in research.
Purpose of the Study:
- To investigate if cognitive benefits of the FINGER multi-domain lifestyle intervention varied by baseline dementia risk, assessed using the LIfestyle for BRAin Health (LIBRA) score.
- To examine the intervention's effect on changes in the LIBRA score over time.
Main Methods:
- Post hoc analyses of 1207 participants from the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER).
- Assessment of cognitive benefits related to baseline dementia risk (LIBRA score) and intervention effects on LIBRA score changes over a 2-year period.
Main Results:
- Higher baseline LIBRA scores were associated with less cognitive improvement, irrespective of the intervention group.
- The multi-domain lifestyle intervention effectively reduced LIBRA scores over time.
- Intervention effectiveness on LIBRA scores was consistent across different baseline demographics and cognitive statuses.
Conclusions:
- The cognitive benefits of the FINGER intervention were consistent across individuals with varying baseline LIBRA scores.
- The LIBRA score shows promise as a surrogate endpoint and surveillance tool for monitoring intervention success in dementia prevention trials.


